Pfizer Inc

Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
U.S. President Donald Trump speaks to the media during the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to […]
Read More
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes — sending shares soaring more […]
Read More
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
People shop at a grocery store in Manhattan on April 01, 2025, in New York City. Spencer Platt | Getty Images A day without major tariff developments from U.S. President Donald Trump’s administration is, for markets, a day of cautious optimism (or at least what passes as “optimism” in such unusual times). There was breathing […]
Read More
Stocks making the biggest moves midday: Apple, Alibaba, Palantir Technologies and more
Check out the companies making headlines in midday trading: Apple — The stock added more than 2% as sentiment on tech shares broadly rose Monday. President Donald Trump announced on Friday that several electronic devices and components will be exempt from U.S. tariffs . The policy benefits Apple given that the majority of the iPhone […]
Read More
Stocks making the biggest moves premarket: Apple, Nvidia, Goldman Sachs, Pfizer and more
Check out the companies making headlines before the bell: Goldman Sachs — The investment bank gained nearly 2% after reporting a top- and bottom-line beat in the first quarter. Goldman Sachs posted earnings of $14.12 per share, while analysts had called for $12.35, according to LSEG. Revenue of $15.06 billion also beat consensus expectations for […]
Read More
Pfizer scraps daily weight loss pill after liver injury in one patient
Nikos Pekiaridis | Lightrocket | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in […]
Read More
Stocks making the biggest moves midday: Apple, Tesla, AbbVie, Delta Air Lines and more
Check out the companies making headlines in midday trading: Apple — Shares rebounded more than 5% on Wednesday after several days of selling pressure on the iPhone maker. Apple manufactures much of its products in China, which has been a key worry for investors in recent days in light of President Donald Trump’s 104% tariff […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more
Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he’s going to announce ” very shortly a major tariff on pharmaceuticals .” Pfizer and Merck shares each dropped more than 4%, while Eli Lilly shed […]
Read More